PMC:7464876 / 61057-61806 JSONTXT

{"target":"http://pubannotation.org/docs/sourcedb/PMC/sourceid/7464876","sourcedb":"PMC","sourceid":"7464876","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7464876","text":"Figure 4 Viral HBV L, but not subviral HBV S, colocalizes with ERGIC-53 upon ER export block. (A) Domain structures of the S and L proteins (left), their transmembrane topology at the ER (middle) and HBV subviral particle (SVP) and VP types (right). The red circles depict the N-glycan acceptor N146. (B,C) Cells were treated with the indicated RNA duplexes for 2 days and retransfected with pHBV.S (B) or pHBV* (C). After an additional two days, cells were fixed with PFA and stained with either rabbit anti-S (K38, S, green) (B) or rabbit anti-L (57761, L, green) (C) plus mouse anti-ERGIC-53 (red) antibodies. DNA staining is shown in blue. Overlaid images (yellow) are displayed in the Merge panels with magnifications and PCC data. Bar, 10 µM.","divisions":[{"label":"label","span":{"begin":0,"end":8}}],"tracks":[]}